LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
208
via globenewswire.comBusiness & Companies

Recursion aligns with FDA on Phase 3 design for REC-4881 in FAP

FROM THE WIRE · GLOBENEWSWIRE.COM

REC-4881 is among the first AI-enabled programs to advance a registrational Phase 3 trial design for a disease with no approved pharmacologic therapies. Its potential as a first-in-class oral therapy for FAP was identified through unbiased phenotypic screening using Recursion's…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishA key regulatory step for an AI-discovered program in an indication with no approved therapies.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Recursion reached alignment with the FDA on the registrational Phase 3 design for REC-4881.
  2. 02The drug targets familial adenomatous polyposis, which has no approved pharmacologic therapies.
  3. 03The candidate was identified through phenotypic screening using Recursion's AI foundation models.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.